2018-12-03 FDA grants breakthrough device designation to artificial intelligence software for CTEPH pattern recognition from Bayer and MSD
2018-11-27 U.S. FDA approves Larotrectinib, the first TRK inhibitor, for patients with advanced solid tumors harboring an NTRK gene fusion
